Aurobindo Pharma Under US FDA Scrutiny: Eight Observations Made

Aurobindo Pharma Under US FDA Scrutiny: Eight Observations Made

Aurobindo Pharma Under US FDA Scrutiny: Eight Observations Made Aurobindo Pharma announced on Friday that the US Food and Drug Administration (FDA) has issued a Form 483 containing eight observations after conducting an inspection of its Telangana-based manufacturing facility.The inspection, which took place from August 25 to September 5 at the company's Unit-XII in Bachupally, involved examining both oral solids and injectable manufacturing uni…

USFDA Issues Form 483 With Eight Observations To Aurobindo's Telangana Unit

Aurobindo Pharma on Friday said the US health regulator has issued a Form 483 with eight observations after inspecting its Telangana-based manufacturing plant.The US Food and Drug Administration inspected the company's Unit-XII, which includes both oral solids and injectable manufacturing units, situated at Bachupally, Telangana from August 25 to September 5, the Hyderabad-based drug firm said in a regulatory filing.At the end of the current ins…